Category of the product: Product from cannabis for medical use
Type of ATC Product: §▲KANOBIL® HIV is dispensed on prescription in duplicate upon recommendation of medical doctor.
▲ triangle – absolute prohibition on driving a motor vehicle or handling machines.
§ – narcotic drug
Product Name: KANOBIL® HIV
Generics: tetrahydrocannabinol (THC), cannabidiol (CBD)
Oil solution for oral administration
(2,5 mg tetrahydrocannabinol (THC) and
1 mg cannabidiol (CBD))/ 1 ml
(300 mg tetrahydrocannabinol (THC) and
120 mg cannabidiol (CBD))/120 ml
The text is not intended for self-medication!
Text is intended for informative purposes of healthcare workers.
NAME OF PRODUCT
tetrahydrocannabinol (THC), cannabidiol (CBD)
POSOLOGY AND METHOD OF ADMINISTRATION
Stick strictly to the recommendations from your doctor. The therapy has to be recommended and monitored by a doctor. Your doctor will tell you how many doses per day you should take and when.
You must not change the doses or discontinue the treatment without consulting your doctor.
KANOBIL® HIV is for oral use. Shake the bottle before use. Use the plastic graduated oral syringe for pulling out a dose of the oil solution which is equal to the dose in accordance to the scheme given by your doctor.
Carefully press to release the content of the oral dosing syringe in the mouth and slowly swallow.
Depending on the condition for which this medicine is taken, your doctor will recommend the daily dose of KANOBIL® HIV according to the following schemes:
The therapy with KANOBIL® HIV includes:
A period of titration and a maintenance period, complying with the dosing scheme:
The period of titration usually lasts for 2 weeks and includes:
-Evaluation of the severity of the patient’s symptoms, before starting and during the therapy, by using VAS value scale for the appetite and the feeling of fullness regarding the food intake;
-The amount of the energy intake – evaluated as a number of calories or number of meals taken per day.
-Gradual increase of the dose until achieving the desired effect: increasing the weight and stopping the loss of weight with as small number of side effects as possible.
-When the desired effect is reached with the titration, the dose shouldn’t be further increased regardless of whether the dose reached is the maintenance dose or not.
-If during the titration moderate adverse events occur (usually a feeling of dizziness), the dose should be decreased, in particular, a daily dose per day gradually (in reverse order from increasing).
-If any severe side effects occur during the titration, the therapy should be discontinued.
-The dose reached during the titration which is in the frames of the maximal recommended daily dose and is well tolerable is the Maintenance dose.
-The maximal daily dose of THC is 37,5mg/day.
Upon a recommendation of a doctor, the dose can be decreased or increased.
PERIOD OF TITRATION
2 p.m. and 6p.m.
in the afternoon)
quantity of the oil solution (ml)
quantity of the oil solution (ml)
|Total daily quantity
of oil solution (ml)
|Total daily dose
THC/ CBD (mg)
KANOBIL® HIV is not recommended for use in children and adolescents aged below 18, due to lack of safety and efficacy information.
|(2,5 mg tetrahydrocannabinol (THC) and 1 mg cannabidiol (CBD))/ 1 ml
(300 mg tetrahydrocannabinol (THC) and 120 mg cannabidiol (CBD))120 ml
|KANOBIL® HIV can be used in adult patients as add-on therapy to the regular therapy for:
HIV infections – to improve symptoms of:
-Weight loss and impaired appetite, when there is intolerance to megestrol acetate or the therapy with megestrol acetate does not give the expected results.
|Do not take KANOBIL® HIV if:
-if you are allergic to cannabinoids or any of the excipients of this medicine;
|A box with a glass bottle containing 120 ml of the oil solution (equal to 120 doses) and a plastic graduated dosing syringe.|